{"id":165638,"name":"ENDO PHARMACEUTICALS","slug":"endo-pharmaceuticals","state":"DC","country":"United States of America","description":"Pharmaceutical Company","totalSpending":30000,"filings":1,"yearlySpending":[{"year":2018,"income":30000}],"issues":["TAX","HCR"],"firms":["CAPITOL HILL CONSULTING GROUP"],"lobbyists":["DAVID JORY","BRIAN SUTTER","WILLIAM SOUTHERLAND","THOMAS WHARTON","SURYA GUNASEKARA"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Taxation/Internal Revenue Code\nIssues relating to incentives for life sciences research. \nTreatment of inbound companies in comprehensive tax reform; Treasury regulations relating to Section 385.","Issues relating to prescription drug abuse.\nIssues relating to incentives for tamper-resistant formulations.\nIssues relating to FDA approvals of new drugs and generic drugs.\nIssues related to the FDA\n"],"years":[2018]}